옵션 체인은 다양한 행사가격과 만기일에 대한 Elicio Therapeutics의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Elicio Therapeutics에 대한 시장 심리를 평가합니다..

Elicio Therapeutics (NASDAQ:ELTX) 주식, 옵션 체인

Elicio Therapeutics

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TMCI

TXNM

VIAV

WILC

버서스 시스템즈(NASDAQ:VS)의 주가는 회사가 국제적인 입지를 성장시키기 위한 전략의 일환으로 회사가 브라질 시장으로의 확장을 발표한 후 급등했다. 버서스 시스템즈의 주가가 금요일 프리마켓 거래에서 71.2% 상승하여 $3.39에 거래되었다.

버서스 시스템즈 주식이 약 71% 상승한 이유: 프리마켓에서 움직이는 20개의 주식

Elicio Therapeutics Inc

&nbsp;Today, Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety trial investigating once-weekly subcutaneous CagriSema (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to placebo. The trial included 1,206 randomised people with obesity or overweight and type 2 diabetes and a mean baseline body weight of 102 kg. &nbsp;The trial achieved its primary endpoint by demonstrating a statistically significant and superior weight loss at week 68 with CagriSema versus placebo. The REDEFINE 2 trial was based on a flexible protocol, allowing patients to modify their dosing throughout the trial. After 68 weeks, 61.9% of patients treated with CagriSema were on the highest dose. When evaluating the effects of treatment, if all people adhered to treatment1, people treated with CagriSema achieved a superior weight loss of 15.7% after 68 weeks compared to 3.1% with placebo. Weight loss of 5% or more after 68 weeks was a co-primary endpoint and was achieved by 89.7% of patients on CagriSema, compared to 30.3% by placebo. When applying the treatment policy estimand2, people treated with CagriSema achieved a superior weight loss of 13.7% compared to 3.4% with placebo. &nbsp;In the trial, CagriSema appeared to have a safe and well-tolerated profile. The most common adverse events with CagriSema were gastrointestinal, and the vast majority were mild to moderate and diminished over time, consistent with the GLP-1 receptor agonist class.&nbsp;

Novo Nordisk Reports Phase 3 Results for CagriSema, Showing 15.7% Weight Loss Over 68 Weeks

U.S. stocks settled higher on Friday, with the Dow Jones index gaining more than 200 points during the session. However, the index recorded losses last week.
The S&amp;P 500 recorded its worst week since September, falling 3.1% last week. The Dow declined 2.4%, while the Nasdaq Composite tumbled 3.5% during the week.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Jay McCanless
<ul>
<li>Analyst Firm: Wedbush</li>
<li>Ratings Accuracy: 87%</li>
<li>Latest Rating: Reiterated an Outperform rating on Landsea Homes Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSEA#NASDAQ">LSEA</a>) with a price target of $15 on March 5. This analyst sees around 108% upside in the stock.</li>
<li>Recent News: On Feb. 27, the company posted record fourth quarter home sales revenue of $450.6 million.</li>
</ul>
Analyst: Lloyd Walmsley
<ul>
<li>Analyst Firm: UBS</li>
<li>Ratings Accuracy: 86%</li>
<li>Latest Rating: Maintained a Neutral rating on Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) and cut the price target from $2 to $1.2 on March 4. This analyst sees around 2% decline in the stock.</li>
<li>Recent News: On Feb. 27, Opendoor Technologies posted upbeat fourth-quarter results.</li>
</ul>
Analyst: Trevor Walsh 
<ul>
<li>Analyst Firm: Citizens Capital Markets</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Reiterated a Market Outperform rating on CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a price target of $400 on March 5. This analyst sees around 20% upside in the stock.</li>
<li>Recent News: On March 4, CrowdStrike reported fourth-quarter revenue of $1.058 billion, beating the consensus estimate of $1.032 billion.</li>
</ul>
Analyst: Josh Sullivan
<ul>
<li>Analyst Firm: Benchmark</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Reiterated a Buy rating on BlackSky Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NASDAQ">BKSY</a>) with a price target of $17 on March 7. This analyst sees around 72% upside in the stock.</li>
<li>Recent News: On March 6, BlackSky Technology reported worse-than-expected fourth-quarter financial results.</li>
</ul>
Analyst: Zachary Fadem
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Maintained an Equal-Weight rating on Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) and cut the price target from $89 to $85 on March 5. This analyst sees around 7% upside in the stock.</li>
<li>Recent News: On March 4, the company reported a fourth-quarter sales decline of 4.8% year-on-year to $13.948 billion, beating the analyst consensus estimate of $13.702 billion..</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44187903/top-2-consumer-stocks-that-could-blast-off-this-quarter">Top 2 Consumer Stocks That Could Blast Off This Quarter</a></li>
</ul>

Price Target

Analyst Ratings

BlackSky Technology Inc. Class A Common Stock

BKSY

CRWD

LSEA

OPEN

This Analyst With 85% Accuracy Rate Sees More Than 20% Upside In CrowdStrike - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

Guidance

Franco-Nevada Expect 2025 Revenue To Be Higher Over 25% YoY, Total GEO Sales Of 465,000 to 525,000 GEO

Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.89 by 6.74 percent. This is a 5.56 percent increase over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $321.00 million which beat the analyst consensus estimate of $305.85 million by 4.95 percent. This is a 5.84 percent increase over sales of $303.30 million the same period last year.

Earnings

Earnings Beats

Franco-Nevada Q4 2024 Adj EPS $0.95 Beats $0.89 Estimate, Sales $321.00M Beat $305.85M Estimate

The establishment of a Strategic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) Reserve and a Digital Asset Stockpile in the U.S. represents a new paradigm in the evolution of cryptocurrencies and one that could influence monetary policy in countries around the world.
While Bitcoin will have its own reserve, the Digital Asset Stockpile is expected to have Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>), and Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), according to <a href="https://www.benzinga.com/25/03/44068814/bitcoin-ethereum-dogecoin-rally-on-trumps-strategic-crypto-reserve-announcement-cardano-xrp-solana-skyrocket-analyst-says-btcs-new-ath-possible-later-in-the-month">Trump&#8217;s earlier announcement</a>.
The connecting thread among them all? They are the largest cryptocurrencies by market capitalization. In fact, excluding stablecoins, the reserve will contain five of the top six coins in terms of valuation.
But, if it was so obvious, the next logical question is why BNB Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>), the fourth-largest cryptocurrency, was not included in the reserve.
Several analysts that Benzinga spoke to blamed it on the ‘China' angle.&nbsp;
<h2 class="wp-block-heading">Ties With An &#8216;Unfriendly&#8217; Trade Partner</h2>
"President Trump's decision to omit Binance Coin from the U.S. Crypto Reserve, despite its substantial market capitalization, may well have been influenced by the ongoing trade tensions between the U.S. and China, as Binance has strong ties to China," said Shant Kevonian, CEO and founder of Web3 email platform EtherMail.
It's worth noting that Binance was initially headquartered in China but moved out before the Chinese government <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40985461/china-controls-55-of-bitcoin-hashrate-despite-crypto-ban-but-the-us-is-catching-up">restricted cryptocurrency trading</a> in the country. As of this writing, the company has no official headquarters.
See Also:<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39359780/dogecoin-shiba-inu-floki-are-dino-coins-says-trader-he-likes-these-3-other-meme-coins-as-b?itm_source=parsely-api"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44212481/dogecoin-plunges-9-but-top-analyst-believes-meme-coin-could-stage-a-strong-rebound-in-case-this-happens">Dogecoin Plunges 9% But Top Analyst Believes Meme Coin Could Stage A &#8216;Strong&#8217; Rebound In Case This Happens</a>
Kadan Stadelmann, blockchain developer and Chief Technology Officer of Komodo Platform, also emphasized the Chinese nationality of Yi He, the company's <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36468045/changpeng-zhao-is-out-but-yi-he-stays-inside-the-unseen-power-of-binances-co-founder">little-known co-founder</a>, apart from Changpeng "CZ" Zhao.
It's not news that Trump <a href="https://www.benzinga.com/25/03/44161587/is-china-apprehensive-of-losing-the-trade-war-to-the-us-china-could-get-isolated-like-moscow-fears-xi-jinping">champions an "America First"</a> policy, placing it at the center of his political rhetoric. He has spoken about putting the U.S. at the forefront of cryptocurrency innovation and avoiding ceding the space to China.
However, the China link wasn't the only cause for concern.
<h2 class="wp-block-heading">Is BNB CZ-Tainted?</h2>
"BNB was started and majority-owned by CZ—in fact, that&#8217;s how Binance funded itself for the 2017 ICO. CZ was recently jailed by the U.S. (Biden administration) for improper KYC, so there&#8217;s no way they&#8217;d include it in a strategic reserve," said Michael Terpin, CEO of Transform Ventures and author of the book Bitcoin Supercycle.
Indeed, CZ served a four-month prison sentence <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38547115/ex-binance-ceo-changpeng-zhao-sees-crypto-industry-entering-new-phase">for anti-money laundering violations</a>, paid a $50 million fine, and stepped down from the CEO's role.&nbsp;
Moreover, according to a Forbes <a href="https://www.forbes.com/sites/javierpaz/2024/06/14/how-cryptos-richest-billionaire-doubled-his-net-worth-behind-bars/">report</a>, he owns an estimated 94 million BNB tokens, roughly 64% of the total circulating supply.
Binance has yet to respond to Benzinga's request for comment on the exclusion from the reserve.
See Also:<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39359780/dogecoin-shiba-inu-floki-are-dino-coins-says-trader-he-likes-these-3-other-meme-coins-as-b?itm_source=parsely-api"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44212481/dogecoin-plunges-9-but-top-analyst-believes-meme-coin-could-stage-a-strong-rebound-in-case-this-happens">Dogecoin Plunges 9% But Top Analyst Believes Meme Coin Could Stage A &#8216;Strong&#8217; Rebound In Case This Happens</a>
<h2 class="wp-block-heading">Litecoin&#8217;s Privacy: The Reason Behind Exclusion?</h2>
Another popular coin whose exclusion might have surprised some was Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>).&nbsp;
After all, the altcoin is <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43047964/litecoin-surges-12-after-analyst-says-altcoin-most-likely-to-have-next-etf-after-bitcoin-ethereum">expected to be the next exchange-traded fund</a> on Wall Street after Bitcoin and Ethereum, with characteristics deemed "very" similar to the apex cryptocurrency.
So, what happened?
Stadelmann believes a privacy-friendly update executed by the Litecoin network in 2022 could be the reason.
"Perhaps Litecoin's 2022 MimbleWimble update, which allows for private transactions where only the sender and receiver know the details, gives Trump pause," Stadelmann told Benzinga.&nbsp;
Notably, the newly added privacy features created a storm, leading to <a href="https://upbit.com/service_center/notice?id=2714">delisting</a> from South Korean cryptocurrency exchanges over conflict with the country's reporting requirements.  
In its defense. Litecoin has stated that MimbleWimble is an <a href="https://www.benzinga.com/markets/cryptocurrency/20/10/17746253/maker-cardano-litecoin-american-wrap-1012020">optional feature</a>.
A spokesperson from the Litecoin Foundation backed LTC's inclusion in a U.S. cryptocurrency reserve and expressed optimism that things could change for the better.
"We are hopeful that thoughtful consideration is given to projects that can provide long-term value for a crypto reserve, and we are confident that if a crypto reserve is passed in Congress, that Litecoin would inevitably be added, given its similar characteristics to Bitcoin and value proposition."
Photo Courtesy: Matt Fowler KC on Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44212604/peter-schiff-establishes-personal-strategic-bitcoin-reserve-vows-not-to-sell-going-down-with-the-ship-so-others-never-get-on-board">Peter Schiff Establishes Personal &#8216;Strategic Bitcoin Reserve,&#8217; Vows Not To Sell: &#8216;Going Down With The Ship So Others Never Get On Board&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

$ADA

$BNB

$BTC

$ETH

$LTC

$SOL

$XRP

Trump Excluded Binance Coin And Litecoin From US Crypto Reserves,  Analysts Say China, CZ's Past And Privacy Concerns Behind The Move

Brown & Brown (Europe) Ltd. Acquires 100% Of The Share Capital Of Premier Commercial Ltd; Consideration Undisclosed

BECN

QXO And Beacon Roofing Supply Confirm Discussions About Potential Combination, In Which QXO Would Acquire Beacon For $124.35 Per Share In Cash, Or ~$11B

MannKind Corporation (NASDAQ:<a href="https://www.benzinga.com/stock/MNKD#NASDAQ">MNKD</a>), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, will showcase data from recent studies of inhaled insulin across five presentations at the 18th International Conference on Advanced Technologies and Treatments for Diabetes to be held March 19-22 in Amsterdam.

MNKD

MannKind to Present New Inhaled Insulin Data at Global Diabetes Conference in Amsterdam

On March 11, Nothing will begin shipping its new Phone (3a) series, offering premium features under $500—but with a few trade-offs that budget buyers should consider.
What Happened: London-based tech startup Nothing announced the Phone (3a) and Phone (3a) Pro, priced at $379 and $459 respectively last week.
The Phone (3a) went on sale March 4 and ships starting March 11, while the (3a) Pro will be available for purchase March 11 and begins shipping March 25.
Both phones run on the Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) Snapdragon 7s Gen 3 processor, with 12 GB of RAM, 256 GB of storage, and 5,000 mAh batteries.
See Also:&nbsp;<a href="https://in.benzinga.com/government/regulations/25/03/44190445/palantir-delivers-ai-powered-battle-stations-to-us-army-stock-now-comparable-to-tesla-circa-2015-analyst" target="_blank" rel="noreferrer noopener">Palantir Delivers AI-Powered Battle Stations To US Army, Stock Now Comparable To Tesla Circa 2015: Analyst</a>
The 6.77-inch AMOLED displays offer up to 3,000 nits peak brightness and adaptive refresh rates from 30 to 120 Hz.
Camera hardware includes a 50-MP main sensor, 8-MP ultrawide, and a telephoto lens—2X optical zoom on the 3a, and 3X on the Pro. The Pro also upgrades the selfie camera to 50 MP.
A standout feature is the new AI-powered Essential Key, which captures screenshots or voice notes and uses the Essential Space app to extract relevant information and tasks.
However, the phones lack wireless charging and IP68 water resistance. With only IP64 certification, they can withstand rain but not submersion.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It's Important: The launch of the Phone (3a) series comes as Nothing <a href="https://www.bloomberg.com/news/articles/2025-01-16/phone-startup-nothing-raises-funding-crosses-1-billion-in-lifetime-sales">reportedly</a> seeks to raise at least $100 million in Series C funding to expand operations.
Founded in 2021 by OnePlus co-founder Carl Pei, the company is backed by Google's venture arm and iPod creator Tony Fadell.
Nothing doubled its revenue to over $500 million in 2024 and surpassed $1 billion in lifetime sales, with 7 million units sold across all product categories.
While its top markets are India, Germany, and the U.K., Nothing plans a larger U.S. expansion in 2026.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Introducing Phone (3a) Series &#x7C; Nothing TV" width="500" height="281" src="https://www.youtube.com/embed/ZizbGaSnIUE?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44149586/credo-expands-hyperscaler-partnerships-with-amazon-microsoft-xai-amid-nvidia-powered-ai-boom" target="_blank" rel="noreferrer noopener">Analysts Highlight Credo Hyperscaler Partnerships With Amazon, Microsoft, xAI Amid AI Boom</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Nothing

Tech

QCOM

Nothing Launches Phone (3a), (3a) Pro With Flagship Specs Under $500: Shipping Starts March 11, But No Wireless Charging Or IP68 Rating

Synaptics&#xAE; Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYNA#NASDAQ">SYNA</a>) has extended its award-winning <a href="https://www.globenewswire.com/Tracker?data=0-1pbe1v1q0ZNJAP1GbYFqIsMSRWZaq07vlu_2CXk_LIBcaL-TWg_qltBrDtme7nams91tAt9yQQVWaDdbEIEMlIcVHx8JJKEti070yJvAg=">Veros</a>&#x2122; Triple Combo connectivity portfolio with the <a href="https://www.globenewswire.com/Tracker?data=out_mtCn-dfAigox-KNrXpp8e1fW1c62S_N1LrevI10F3JfVNus-1yYOlivq1oqeggJYA8Cf2_xfG5D_GjHPbthxo0WHqQmey4vxtmPzJOPu9f4agxGvorOFQsiqVjA0UNDyukgPWHfU19u08_0gRmWq28X0FHZ5coHTLEeHQwvNERqMdOK89kyi55-lVNIA">SYN461x</a> family of ultra-low-power (ULP) Wi-Fi&#xAE; 2.4/5/6 GHz, Bluetooth&#xAE; 6.0 and Bluetooth Low Energy (BLE), and IEEE 802.15.4 (Zigbee&#xAE;/Thread&#xAE;) systems on chip (SoCs). Designed for the embedded Edge AI Internet of Things (IoT), the SYN461x is optimized for power, system integration, size, and rapid time to market while delivering Veros' characteristic outstanding rate-over-range performance and seamless interoperability. The versatile Matter-compliant SoCs offer advanced Bluetooth features, such as Channel Sounding and LE Audio—including Auracast&#x2122;. The SYN461x specifically targets consumer and industrial applications and is tailored for devices such as wearables, smart watches, audio speakers and headsets, home appliances, security cameras, asset trackers, and factory automation.

SYNA

Synaptics Boosts Edge AI IoT With New Ultra-Low-Power Chip for Smart Homes, Audio, and Industrial Tech

Fennec Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses of $(0.10) per share from the same period last year. The company reported $7.92 million in sales this quarter. This is a 18.59 percent decrease over sales of $9.73 million the same period last year.

FENC

Fennec Pharmaceuticals Q4 2024 GAAP EPS $(0.06) Up From $(0.10) YoY, Sales $7.92M Down From $9.73M YoY

Brand Engagement Network Inc. ("BEN") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>), a global provider of conversational AI agents, has expanded its reseller partnership with Vybroo, a leader in AI-driven voice technology and division of Teleradionetworks S.A. de C.V. and Grupo Vibra Medios, a prominent radio broadcasting network in Mexico. The expanded partnership, which was initially announced in <a href="https://www.globenewswire.com/Tracker?data=MdD1hro-ZSlxjWV_lty7SraiVC59IJQAaCZo9kRdUGThq-cmAQ2BMjcS98JYDZPNGbnI2Imjp4LXvZKmB2tdHTiU8w1e73nteAi_NtQtayvZ_JgRPAia9cK6TPyP1cRAfgHv3pKLKOAneeVFzen2L3ZW6TK_J-RtbF28Dc1F-ZzzwABkqNQt957gCmQ3SlK_OkrHYet_FPmglCO6VqZz1g==">July 2024</a>, will offer AI-powered solutions across Latin America, Spain, Portugal, and Italy, strengthening BEN's presence in AI-enabled digital media through Vybroo's extensive advertising network and Grupo Siete's media platforms, unlocking new revenue opportunities in high-growth markets.
As part of the initiative, Grupo Vibra Medios and Grupo Siete, a leading Mexican media and broadcasting company that operates multiple radio stations, including Radio Disney Mexico, will deploy five AI-powered brand ambassador avatars developed by BEN to drive engagement across various platforms for its advertising clients. This pilot program will introduce QR code activations, enabling real-time consumer interactions that deliver promotions, product information, and personalized engagement.
BEN and Vybroo have also collaborated to develop an AI-powered digital persona, Roquito, modeled after Vybroo CEO and radio icon Roque Mascareño. Roquito leverages BEN's advanced conversational AI capabilities, offering businesses massively scalable, tailored engagement solutions that strengthen customer connections while optimizing costs.

BNAI

Brand Engagement Network Expands AI Partnership With Vybroo, Taps Radio Disney Mexico and Grupo Vibra to Deploy AI Brand Ambassadors Across Latin Markets

Contracts

KBR Secures Firm Fixed Price, $85M Task Award From US Air Force To Procure, Design And Deliver Critical Training Aids And Airfield Damage Repair Kits Globally

Biotech

Health Care

Financing

Offerings

General

BEAM

Beam Therapeutics Priced Underwritten Offering Of 16.15M Shares At $28.48 Per Share, And Pre-funded Warrants To Purchase 1.40M Shares At $28.47 Per Pre-funded Warrant, With Gross Proceeds Of Of Approximately $500M

Beneficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) ("Beneficient," "Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, today announced that it has entered into a binding agreement to settle all claims in the previously disclosed lawsuits relating to GWG Holdings, Inc. ("GWG") in federal court in the Northern District of Texas and the Bankruptcy Court for the Southern District of Texas ("GWG Litigation") against the Company, its subsidiaries, and each of their current and former directors and officers, including its founder and CEO, Brad Heppner (collectively, the "Beneficient Parties"), for a sum within applicable insurance policy limits.

Legal

BENF

Beneficient Ends Legal Battle Over GWG With Settlement, Clears Path for Focus on AltAccess Platform

Buybacks

PERI

Perion Network Board Authorizes $50M Expansion Of Prior Share Repurchase Program Of $75M Of Its Outstanding Shares, To Total Of $125M

The GEO Group, Inc. (NYSE:<a href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) ("GEO" or the "Company") announced today that U.S. Immigration and Customs Enforcement ("ICE") has entered into a contract modification of the current intergovernmental service agreement ("IGSA") for the GEO-owned, 1,328-bed Karnes ICE Processing Center (the "Center) in Karnes City, Texas to transition the Center from housing adult males only to housing mixed populations. GEO provides support services for ICE at the Center under an IGSA between Karnes County and ICE, that is effective through August 2029. GEO's support services include the exclusive use of the Center by ICE, along with security, maintenance, and food services, as well as access to recreational amenities, medical care, and legal counsel.
Under the revised IGSA, GEO is expected to generate approximately $79 million in annualized revenues in the first full year of operations, which is expected to represent incremental annualized revenues of approximately $23 million, with margins consistent with GEO's company-owned Secure Services facilities.

GEO Lands $79M Deal With ICE, Expands Karnes Facility Use and Revenue Outlook Through 2029

TRVI

Trevi Therapeutics Reports Topline Results From Its Phase 2a RIVER Trial Of Haduvio For The Treatment Of Patients With RCC (N=66); Says Haduvio Met The Primary Endpoint

<ul>
<li>Single Dose of BEAM-302 Led to Durable, Dose-dependent Increases in Total and Functional Alpha-1 Antitrypsin (AAT), Production of Corrected M-AAT, and Decreases in Mutant Z-AAT in Circulation Across Initial Three Dose Levels</li>
<li>Third Dose Level of BEAM-302 (60 mg, N=3) Achieved Mean Total AAT of 12.4µM at Day 28, Exceeding Protective Therapeutic Threshold, and Reduced Mutant Z-AAT up to 78%</li>
<li>Initial Safety Findings Demonstrated BEAM-302 was Well Tolerated at All Dose Levels with No Serious Adverse Events or Dose-Limiting Toxicities Observed</li>
<li>Clinical Profile Supports Continued Dose Escalation, with Updated Data from Part A of the Phase 1/2 Trial Expected to be Presented at Medical Conference in Second Half of 2025</li>
</ul>

Beam Therapeutics Announced Initial Safety And Efficacy Data From Its Phase 1/2 Trial Of BEAM-302, As Potential Treatment For Alpha-1 Antitrypsin Deficiency And For In Vivo Base Editing

A Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) whale accumulated about $7.5 million in unrealized profit by successfully shorting the apex cryptocurrency amid the ongoing market correction.
What Happened:&nbsp;According to an X post by on-chain tracking platform Lookonchain Sunday, the trader shorted Bitcoin at approximately $96,500 on Feb. 22 and closed the position near&nbsp;the bottom at around $78,900 six days later.
The whale&nbsp;re-entered a short position at&nbsp;the peak of approximately $94,424 following the rally induced by President Donald Trump&#8217;s executive order establishing a <a href="https://in.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise">Strategic Bitcoin Reserve</a>. 
As of this writing, they have set additional short&nbsp;positions at $92,449-$92,636&nbsp;and placed limit orders to&nbsp;take profit between $70,475-$74,192.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A whale has been very good at shorting <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> during recent price drops, with an unrealized profit of over $7.5M! On Feb 22, he shorted <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> at ~$96,500, and within a week, <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> plummeted below $80,000. He closed his short position near the bottom at ~$78,900 with perfect timing.… <a href="https://t.co/wkXOZKnU4O">pic.twitter.com/wkXOZKnU4O</a>
&mdash; Lookonchain (@lookonchain) <a href="https://twitter.com/lookonchain/status/1898911091029409835?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44159088/microsoft-might-have-given-bitcoin-investments-a-miss-for-now-but-one-of-its-largest-investors-has-been-an-avid-advocate-of-cryptos-blockchains">Microsoft May Have Given Bitcoin Investments A Miss But A Large MSFT Stock Holder Is A Strong Crypto, Blockchain Advocate</a>
Why It Matters:&nbsp;The whale&#8217;s successful shorting of Bitcoin comes in the wake of the <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44212362/bitcoin-ethereum-and-dogecoin-crash-as-trump-refuses-to-rule-out-recession-arthur-hayes-predicts-btc-to-retest-78000">broader market crash</a> Sunday evening following Bitcoin&#8217;s fall to $80,000. 
Well-known Bitcoin bull Arthur Hayes predicted a retest of $78,000, with $75,000 next in line if that failed, indicating a convergence with the whale&#8217;s conviction.
The timing of several leveraged trades has sparked speculation of possible insider trading in recent days. Last week, a whale closed their 50x leveraged position on Bitcoin and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) shortly before Trump announced a&nbsp;<a href="https://www.benzinga.com/25/03/44068814/bitcoin-ethereum-dogecoin-rally-on-trumps-strategic-crypto-reserve-announcement-cardano-xrp-solana-skyrocket-analyst-says-btcs-new-ath-possible-later-in-the-month" target="_blank" rel="noreferrer noopener">cryptocurrency reserve</a>, resulting in a profit of over $6 million.
Price Action: At the time of writing, Bitcoin was exchanging hands at $81,575.36, down 5.01% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://in.benzinga.com/25/03/44183572/trump-establishes-strategic-bitcoin-reserve-funded-by-forfeited-assets-i-made-the-promise">Trump Creates Strategic Bitcoin Reserve Funded By Forfeited Assets: &#8216;I Made The Promise&#8217; — BTC Dips 4%</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Successful Bitcoin Short Trader Places Take Profit Levels Between $70,000-$74,000: Further Drop Incoming?

Press Releases

Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines

Elicio Therapeutics Reports Inducement Grants

Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer ("SITC") 2024 Annual Meeting

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Coherus BioSciences

Checkpoint Therapeutics, Inc. - Common Stock

Checkpoint Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

Coya Therapeutics

EXoZymes

Fate Therapeutics

Invivyd

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Seres Therapeutics

Nkarta

ProKidney Corp. - Class A Ordinary Shares

ProKidney

Renovaro

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Sutro Biopharma

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

TScan Therapeutics

Instil Bio

2seventy bio

Vor Biopharma

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Jones Trading

HC Wainwright & Co.

Screenshot 2024-06-07 at 5.22.00 PM

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

Screenshot 2024-04-10 at 5.39.01 PM

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Screenshot 2024-04-04 at 5.26.54 PM

Unlocking The Power Of Immunotherapy: Elicio Therapeutics&#39; (NASDAQ: ELTX) Novel AMP Platform

Comments

Elicio Therapeutics

Elicio Therapeutics (ELTX) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌